Logo image of RBLX

ROBLOX CORP -CLASS A (RBLX) Stock Fundamental Analysis

NYSE:RBLX - New York Stock Exchange, Inc. - US7710491033 - Common Stock - Currency: USD

117.34  -7.94 (-6.34%)

After market: 117.95 +0.61 (+0.52%)

Fundamental Rating

4

RBLX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 74 industry peers in the Entertainment industry. While RBLX seems to be doing ok healthwise, there are quite some concerns on its profitability. RBLX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RBLX has reported negative net income.
In the past year RBLX had a positive cash flow from operations.
RBLX had negative earnings in each of the past 5 years.
RBLX had a positive operating cash flow in each of the past 5 years.
RBLX Yearly Net Income VS EBIT VS OCF VS FCFRBLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

RBLX has a Return On Assets of -12.14%. This is in the lower half of the industry: RBLX underperforms 67.57% of its industry peers.
The Return On Equity of RBLX (-269.61%) is worse than 78.38% of its industry peers.
Industry RankSector Rank
ROA -12.14%
ROE -269.61%
ROIC N/A
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
RBLX Yearly ROA, ROE, ROICRBLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

RBLX has a better Gross Margin (78.01%) than 90.54% of its industry peers.
In the last couple of years the Gross Margin of RBLX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for RBLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
RBLX Yearly Profit, Operating, Gross MarginsRBLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
RBLX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RBLX has been increased compared to 5 years ago.
The debt/assets ratio for RBLX has been reduced compared to a year ago.
RBLX Yearly Shares OutstandingRBLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
RBLX Yearly Total Debt VS Total AssetsRBLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

RBLX has an Altman-Z score of 5.61. This indicates that RBLX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.61, RBLX belongs to the top of the industry, outperforming 82.43% of the companies in the same industry.
RBLX has a debt to FCF ratio of 1.07. This is a very positive value and a sign of high solvency as it would only need 1.07 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.07, RBLX belongs to the top of the industry, outperforming 85.14% of the companies in the same industry.
A Debt/Equity ratio of 2.85 is on the high side and indicates that RBLX has dependencies on debt financing.
With a Debt to Equity ratio value of 2.85, RBLX is not doing good in the industry: 72.97% of the companies in the same industry are doing better.
Even though the debt/equity ratio score it not favorable for RBLX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 2.85
Debt/FCF 1.07
Altman-Z 5.61
ROIC/WACCN/A
WACC8.9%
RBLX Yearly LT Debt VS Equity VS FCFRBLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.97 indicates that RBLX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.97, RBLX is in line with its industry, outperforming 54.05% of the companies in the same industry.
RBLX has a Quick Ratio of 0.97. This is a bad value and indicates that RBLX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of RBLX (0.97) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
RBLX Yearly Current Assets VS Current LiabilitesRBLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

7

3. Growth

3.1 Past

RBLX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.60%, which is quite good.
Looking at the last year, RBLX shows a very strong growth in Revenue. The Revenue has grown by 27.39%.
The Revenue has been growing by 47.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)18.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.12%
Revenue 1Y (TTM)27.39%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%50.51%

3.2 Future

Based on estimates for the next years, RBLX will show a very strong growth in Earnings Per Share. The EPS will grow by 25.51% on average per year.
The Revenue is expected to grow by 21.04% on average over the next years. This is a very strong growth
EPS Next Y0.82%
EPS Next 2Y8.65%
EPS Next 3Y13.2%
EPS Next 5Y25.51%
Revenue Next Year23.83%
Revenue Next 2Y23.1%
Revenue Next 3Y20.24%
Revenue Next 5Y21.04%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RBLX Yearly Revenue VS EstimatesRBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
RBLX Yearly EPS VS EstimatesRBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RBLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RBLX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBLX Price Earnings VS Forward Price EarningsRBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of RBLX indicates a somewhat cheap valuation: RBLX is cheaper than 62.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 84.5
EV/EBITDA N/A
RBLX Per share dataRBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

RBLX's earnings are expected to grow with 13.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.65%
EPS Next 3Y13.2%

More info and screens

0

5. Dividend

5.1 Amount

RBLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROBLOX CORP -CLASS A

NYSE:RBLX (8/15/2025, 8:04:01 PM)

After market: 117.95 +0.61 (+0.52%)

117.34

-7.94 (-6.34%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners79.53%
Inst Owner Change5.24%
Ins Owners4.97%
Ins Owner Change0.55%
Market Cap79.59B
Analysts76.5
Price Target134.42 (14.56%)
Short Float %3.66%
Short Ratio2.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.17%
Min EPS beat(2)-9.21%
Max EPS beat(2)21.55%
EPS beat(4)3
Avg EPS beat(4)13.56%
Min EPS beat(4)-9.21%
Max EPS beat(4)28.29%
EPS beat(8)7
Avg EPS beat(8)14.35%
EPS beat(12)8
Avg EPS beat(12)6.28%
EPS beat(16)9
Avg EPS beat(16)-3.9%
Revenue beat(2)2
Avg Revenue beat(2)8.35%
Min Revenue beat(2)3.4%
Max Revenue beat(2)13.29%
Revenue beat(4)3
Avg Revenue beat(4)5.57%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)13.29%
Revenue beat(8)5
Avg Revenue beat(8)3.32%
Revenue beat(12)5
Avg Revenue beat(12)-3.21%
Revenue beat(16)5
Avg Revenue beat(16)-7.27%
PT rev (1m)69.87%
PT rev (3m)85.86%
EPS NQ rev (1m)-18.36%
EPS NQ rev (3m)-10.59%
EPS NY rev (1m)0%
EPS NY rev (3m)2.86%
Revenue NQ rev (1m)13.58%
Revenue NQ rev (3m)15.71%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)0.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.78
P/FCF 84.5
P/OCF 74.03
P/B 225.32
P/tB 430.72
EV/EBITDA N/A
EPS(TTM)-1.4
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)1.39
FCFY1.18%
OCF(TTM)1.59
OCFY1.35%
SpS5.93
BVpS0.52
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.14%
ROE -269.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.01%
FCFM 23.41%
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 2.85
Debt/FCF 1.07
Debt/EBITDA N/A
Cap/Depr 58.58%
Cap/Sales 3.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 5.61
F-Score6
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)189.75%
Cap/Depr(5y)192.24%
Cap/Sales(3y)12.06%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.12%
EPS Next Y0.82%
EPS Next 2Y8.65%
EPS Next 3Y13.2%
EPS Next 5Y25.51%
Revenue 1Y (TTM)27.39%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%50.51%
Revenue Next Year23.83%
Revenue Next 2Y23.1%
Revenue Next 3Y20.24%
Revenue Next 5Y21.04%
EBIT growth 1Y7.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.58%
EBIT Next 3Y60.52%
EBIT Next 5Y44.04%
FCF growth 1Y889.49%
FCF growth 3Y4.75%
FCF growth 5Y113.37%
OCF growth 1Y176.66%
OCF growth 3Y7.65%
OCF growth 5Y52.65%